Akebia Therapeutics Inc. buy BTIG Research
Start price
29.11.23
/
50%
€0.92
Target price
29.11.24
€3.64
Performance (%)
122.78%
End price
30.11.24
€2.05
Summary
This prediction ended on 30.11.24 with a price of €2.05. The BUY prediction by BTIG_Research for Akebia Therapeutics Inc. saw massive gains of 122.78%. BTIG_Research has a follow-up prediction for Akebia Therapeutics Inc. where he still thinks Akebia Therapeutics Inc. is a Buy. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Akebia Therapeutics Inc. | 3.927% | 3.927% | -25.376% |
| iShares Core DAX® | 4,85 % | -2,75 % | 13,10 % |
| iShares Nasdaq 100 | 4,00 % | -3,33 % | 31,34 % |
| iShares Nikkei 225® | 4,22 % | -2,91 % | 44,47 % |
| iShares S&P 500 | 3,32 % | -2,95 % | 24,36 % |
Comments by BTIG_Research for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Akebia Therapeutics, Inc. (NASDAQ: AKBA) had its "buy" rating re-affirmed by analysts at BTIG Research. They now have a $4.00 price target on the stock.
Ratings data for AKBA provided by MarketBeat
In the thread Trading Akebia Therapeutics Inc.
Die von BTIG_Research gewählte maximale Laufzeit wurde überschritten
Current prediction by BTIG_Research for Akebia Therapeutics Inc.
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.93
29.10.25
29.10.25
€4.29
29.10.26
29.10.26
-38.17%
02.04.26
02.04.26
Stopped prediction by BTIG_Research for Akebia Therapeutics Inc.
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.08
25.02.26
25.02.26
€3.39
25.02.27
25.02.27
10.78%
02.04.26
02.04.26
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.27
02.12.25
02.12.25
€4.31
02.12.26
02.12.26
-6.44%
02.04.26
02.04.26